BeOne Medicines Ltd. - Sponsored ADR (ONC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended September 2025, BeOne Medicines Ltd. - Sponsored ADR (ONC) reported revenue of $1.41 billion, up 41% over the same period last year. EPS came in at $1.09, compared to -$1.15 in the year-ago quarter. The reported revenue represents a surprise of +5.36% over the Zacks Consensus Estimate of $1.34 billion. With the consensus EPS estimate being $0.72, the EPS surprise was +51.39%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...